Kentaro Kodama

Incidence and risk factors for hyperkalaemia in patients treated for COVID‐19 with nafamostat mesylate

Y. Gon, Kentarou Hayashi, Yasuo Asai, 2022, Journal of clinical pharmacy and therapeutics.

Serum surfactant protein A and D may be novel biomarkers of COVID-19 pneumonia severity

H. Chiba, Hiroki Takahashi, K. Kuronuma, 2020 .

Programmed Death-Ligand 1-Positive Squamous Cell Carcinoma Spontaneously Regressed after Percutaneous Needle Biopsy

H. Chiba, K. Okamoto, Hirotaka Nishikiori, 2023, Medicina.

Feasibility of rapid on‐site cytological evaluation of lung cancer by a trained pulmonologist during bronchoscopy examination

H. Chiba, Hiroki Takahashi, Yuta Sudo, 2019, Cytopathology : official journal of the British Society for Clinical Cytology.

Coronavirus Disease 2019 Vaccine-Induced Flare-Up of Severe Bronchial Asthma Previously Controlled With Dupilumab: A Case Report

H. Chiba, Hirotaka Nishikiori, Toshiyuki Sumi, 2023, Cureus.

Pneumocystis Pneumonia Infection Following the Initiation of Pembrolizumab Therapy for Lung Adenocarcinoma: A Case Report.

K. Takeda, H. Chiba, Hirotaka Nishikiori, 2023, Internal medicine.

Circulating T follicular helper 2 cells, T follicular regulatory cells and regulatory B cells are effective biomarkers for predicting the response to house dust mite sublingual immunotherapy in patients with allergic respiratory diseases

S. Ichimiya, Hirotaka Nishikiori, S. Kamiya, 2023, Frontiers in immunology.